Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer

by Fang-Fei Qian, Bao-Hui Han, Pei-Fang Wei
Published 2020-10-01

A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab

by Wei Nie, Jie Qian, Mi-Die Xu, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Jun Lu, Lu Gan, Xue-Yan Zhang, Shu-Hui Cao, Jing-Wen Li, Yue Wang, Bo Zhang, Shu-Yuan Wang, Fang Hu, Chang-Hui Li, Hua Zhong, Bao-Hui Han
Published 2020-01-01

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

by Wei Nie, Lu Gan, Xin Wang, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Ding Zhang, Shi-Qing Chen, Jun Lu, Shu-Hui Cao, Jing-Wen Li, Yue Wang, Bo Zhang, Shu-Yuan Wang, Chang-Hui Li, Ping Yang, Mi–Die Xu, Xue-Yan Zhang, Hua Zhong, Bao-Hui Han
Published 2021-01-01